Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

merckkgaahq

Merck KGaA posts promising osteoarthritis data

November 6, 2017 Research and Development, Sales and Marketing Merck KGaA, biotech, drugs, pharma, pharmaceutical

Merck KGaA’s share price is 7% down over the course of the year – a year that, on the pharmaceutical …
News
bacteria-1959386_960_720

Gut bacteria may be key to efficacy of immunotherapies

November 6, 2017 Research and Development, Sales and Marketing biotech, drugs, immunotherapy, pharma, pharmaceutical

Why immunotherapies are successful in some individuals and not in others is a matter of huge importance to both patients …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug, pharma, pharmaceuticals, top ten

As we move into November, we bring you another run down of the top ten most popular articles on Pharmafile.com …
News
gsk_boronia_australia

GSK’s experimental multiple myeloma scores Breakthrough designation with FDA

November 3, 2017 Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, GSK, GlaxoSmithKline, multiple myeloma, pharma

GlaxoSmithKline is celebrating the FDA’s decision to award its experimental therapy GSK2857916 with Breakthrough Therapy Designation as a monotherapy in …
News
online

Tissue Regenix promotes new CEO from within

November 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, tissue regenix

Just over two weeks ago, Tissue Regenix announced that its long-standing CEO, Antony Odell, would be leaving the company. It …
Appointment

FDA issues warnings in crackdown on baseless cannabis miracle cures

November 2, 2017 Research and Development, Sales and Marketing FDA, cannabidiol, cannabis, pharma

The FDA has issued a warning over cannabis-based therapies which promise the ability to cure cancer, asserting that such treatments …
News
pregnant-2640994_960_720

New test could determine womens’ risk of miscarriage or premature birth

November 2, 2017 Research and Development biotech, drugs, pharma, pharmaceutical, pregnancy

Scientists in the US have reported findings suggesting that certain molecules in the blood are strongly associated with complications during …
News

Novartis reveals the data behind its showdown with Gilead

November 1, 2017 Research and Development CAR-T, Gilead, Kymriah, Novartis, biotech, drugs, pharma, pharmaceutical

Only yesterday it was revealed that Novartis had applied to the FDA in the same indication that Gilead’s treatment is …
News
csm_tk12_17_rupert_sandbrink_kl_fb0c325239

Topas Therapeutics brings in new CMO

November 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Topas Therapeutics, biotech, drugs, pharma, pharmaceutical

Topas Therapeutics, a German company focused on developing novel therapeutics to treat immune-mediated and autoimmune diseases, announced that it has …
Appointment
_97604447_kymriah-product-shot-8

CAR-T is bringing true precision to the fight against cancer

November 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Gilead, Kymriah, Novartis, Yescarta

Matt Fellows investigates how the first-ever CAR-T therapy approvals in the past months could mean the field of cancer treatment …
Feature
roche

Roche’s Tecentriq approved for funding in UK in bladder cancer

November 1, 2017 Research and Development, Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical

In a rare spot of good news for Tecentriq (atezolizumab), after a turbulent period, Roche’s drug has been given the …
News

Indivior’s opioid addiction treatment recommended by FDA advisory panel

November 1, 2017 Research and Development, Sales and Marketing FDA, RGP-6000, Trump, US, indivior, opioid crisis, opioids

Another step has been made in the fight back against the ongoing opioid crisis in the US as it emerges …
News

CEO and President implicated as price-fixing probe widens

November 1, 2017 Research and Development, Sales and Marketing Mylan, Teva, biotech, drugs, pharma, pharmaceutical

A group of states, 45 members-strong, has expanded its probe into the generics pharmaceutical industry by expanding its case to …
News
astrazeneca-sign

AstraZeneca asthma therapy tralokinumab flops at Phase 3

November 1, 2017 Research and Development AstraZeneca, MedImmune, asthma, pharma

AstraZeneca and MedImmune, the company’s global biologics research and development arm, have announced new Phase 3 data revealing that tralokinumab …
News
nhs_sign

Cancer death rates 61% higher in poorer areas

November 1, 2017 Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical

Figures released by NHS Scotland have revealed that the numbers of deaths from cancer are 67% higher in the poorest …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026